1Fox EM, Davis RJ, Shupnik MA.ERbeta in breast cancer onlooker, passive player, or active protector[J].Steroids, 2008,73(11) : 1039.
2Chen L,Qiu J, Yang X,et al.Identification of a novel estrogen receptor betal binding partner,inhibitor of differentiation-1, and role of ERbetal in human breast cancer cells[J].Cancer Let t ,2009,278 (2):210.
3Lukas J, Gao DQ, KeshmeshianM.Alternative and aberrantmes-senger RNA splicing of the mdm2 oncogene in invasive breast cancer[J]. Cancer Res, 2001,61 : 3212.
4Pettersson K, Delaunay F, Gustaf sson J A.Estrogen receptor β acts as a dominant regulator of estrogen signaling[J].Oncogene, 2000, 19 : 4970.
2Tania Dutta,Himani Sharma,Lalit Kumar,A. K. Dinda,Sunesh Kumar,Neerja Bhatla,Neeta Singh.Neoadjuvant chemotherapy for epithelial ovarian cancer—role of apoptosis[J].Cancer Chemotherapy and Pharmacology.2005(4)
3M. Ikeguchi,J. Liu,N. Kaibara.Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment[J].APOPTOSIS.2002(1)
4O‘Connor D S,Wall N R,Porter A C et al.A p34 (cdc2) survival checkpoint in cancer[].Cancer Cell.2002
